Statistics from Altmetric.com
We read with great interest the article by Wallau and Campos,1 who compared the 1-year outcome of photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK) in a bilateral randomised prospective clinical trial. The authors concluded that Wavefront-guided PRK with 0.002% MMC is more effective than wavefront-guided LASIK for correction of moderate myopia, which is consistent with previous studies.2
We would like to make the following comments.
The authors have conducted a bilateral randomised control trial; however, …